Oncogenic genomic alterations, clinical phenotypes, and outcomes in metastatic castration-sensitive prostate cancer

BACKGROUND: The genomic underpinning of clinical phenotypes and outcomes in metastatic castration-sensitive prostate cancer is unclear. METHODS: In patients with metastatic castration-sensitive prostate cancer at a tertiary referral center, clinical-grade targeted tumor sequencing was performed to q...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cancer Res
Asıl Yazarlar: Stopsack, Konrad H., Nandakumar, Subhiksha, Wibmer, Andreas G., Haywood, Samuel, Weg, Emily S., Barnett, Ethan S., Kim, Chloe J., Carbone, Emily A., Vasselman, Samantha E., Nguyen, Bastien, Hullings, Melanie A., Scher, Howard I., Morris, Michael J., Solit, David B., Schultz, Nikolaus, Kantoff, Philip W., Abida, Wassim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334067/
https://ncbi.nlm.nih.gov/pubmed/32220891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0168
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller